13F

Stock

Vanda Pharmaceuticals Inc.

VNDA · held by 2 managers

Reported value

$314.8K

Holders

2

+0 new · −0 exited

Holders’ est. mark

$95K

Price effect on 2 books still in the name

Largest holder

$308.7K

Henshaw Capital LLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Henshaw Capital LLC14.4K$308.7K$93.1KAdded$93.1K
Leonteq Securities AG286$6.15K$1.86KCut−$188.2K

Positions as of Q2 2021. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.